Target intelligence / Profile preview

Zinc finger protein (ZFP) (ZFP)

Target
ZFP
Molecular classification
Transcription factor, DNA-binding protein, RNA-binding protein, Enzyme, E3 ubiquitin ligase
01

Overview

Zinc finger proteins (ZFPs) constitute one of the most abundant protein families in eukaryotes, defined by the presence of small, functional motifs stabilized by the coordination of zinc ions (UniProt, 2023). These proteins primarily act as transcription factors that bind specific DNA sequences to control the expression of genes involved in cell growth, differentiation, and development (PubMed, 2021). Beyond DNA binding, ZFPs are also involved in RNA metabolism, protein-protein interactions, and the regulation of apoptosis (NIH, 2022). Dysregulation or mutation of ZFPs is frequently observed in various diseases, particularly in oncology where they can act as either oncogenes or tumor suppressors (Nature Reviews Cancer, 2020). For instance, the Wilms tumor 1 (WT1) protein is a well-characterized ZFP that plays a critical role in leukemogenesis and solid tumors (PubMed, 2019). Therapeutic strategies targeting ZFPs include the use of molecular glues like lenalidomide to induce the degradation of Ikaros family proteins (IKZF1/3) via the CRBN E3 ligase (Science, 2019). Additionally, engineered zinc finger nucleases (ZFNs) have been developed for therapeutic gene editing to treat genetic disorders and HIV (Nature Biotechnology, 2021). Despite their potential, targeting ZFPs remains challenging due to the high structural homology between family members, which can lead to off-target effects (Cell, 2022).

Other names
Zinc finger-containing proteinZNF proteinZinc finger motif-containing proteinCys2His2 zinc finger protein
02

Mechanism of action

Molecular glue-induced degradation, competitive inhibition of DNA binding, and site-specific genomic cleavage.

03

Biological functions

Gene expression regulationDNA repairSignal transductionCell differentiationApoptosisProtein-protein interaction
04

Disease associations

CancerNeurodegenerative diseaseViral infectionGenetic disorderInflammation
05

Safety considerations

Off-target DNA bindingSystemic toxicity due to broad expressionImmunogenicity of engineered ZFNsUnintended gene silencing
06

Interacting drugs

Lenalidomide

5 more in the full profile.

07

Biomarkers

WT1 expressionGLI1 expressionIKZF1 levelsIKZF3 levels

Beyond the preview

Go deeper on Zinc finger protein (ZFP) (ZFP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein (ZFP) (ZFP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call